Unusual adverse event with vandetanib in metastatic medullary thyroid cancer

J Clin Oncol. 2012 Jan 10;30(2):e21-3. doi: 10.1200/JCO.2011.38.2796. Epub 2011 Dec 12.

Authors

Sophie Duplomb¹, Amandine Benoit, Laura Mechtouff-Cimarelli, Tae-Hee Cho, Olfa Derbel, Jean Louis Peix, Christelle de la Fouchardière

Affiliation

¹ Medical Oncology Department, Centre Leon Berard, 28 rue Laennec, 69008 Lyon, France.

PMID: 22162581
DOI: 10.1200/JCO.2011.38.2796

No abstract available

Publication types

Case Reports

MeSH terms

Carcinoma, Neuroendocrine
Humans
Male
Middle Aged
Neoplasm Metastasis
Piperidines / administration & dosage
Piperidines / adverse effects*
Quinazolines / administration & dosage
Quinazolines / adverse effects*
Thyroid Neoplasms / drug therapy*
Thyroid Neoplasms / pathology

Substances

Piperidines
Quinazolines
vandetanib

Supplementary concepts

Thyroid cancer, medullary